Public trial registry of the CCC-Munich

Trial APREMINUM

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
APREMINUM
World
Full title
:

An investigator-initiated, randomized, double-blind, placebo controlled study of Apremilast to demonstrate efficacy in subjects with nummular eczema

World
Responsible organization
:
Dermatologie Dermatologie Biedersteiner Str. 29 80802 München Germany
Indications
Classification Code Description
ICD-10-GM L30.0 Nummuläres Ekzem
Trial design
World
Phase
:
II/III
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo

Participants
Function Prename Surname Organization
World Responsible contact Dermatologie Dermatologie Biedersteiner Str. 29 80802 München Germany Magnifier